Cancer clinical trials in the region Nouvelle-Aquitaine
294 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Colon cancer
Rectal cancer
Pancreas cancer
Stomach and esophageal cancer
#NCT06937905
Neuroendocrine tumor
Locally Advanced
Metastatic
1
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Universitaire Dupuytren (Limoges), Groupe Hospitalier Saint André (Bordeaux), CHU - Haut-Lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Intergroupe Francophone de Cancérologie Thoracique
Phase 3
Colon cancer
Rectal cancer
#NCT06107920
Adenocarcinoma
Localized
MSS/pMMR
None
Surgery
Chemotherapy
Radiotherapy
Centre Hospitalier Universitaire Dupuytren (Limoges)
Hôpital universitaire de Rouen
Phase 3
Breast cancer
#NCT06435429
HER2 Positive
Locally Advanced
Metastatic
1
2
3 or more
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Jazz Pharmaceuticals
Phase 3
Breast cancer
#NCT06435429
HER2 Positive
Locally Advanced
Metastatic
1
2
3 or more
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut Bergonié (Bordeaux)
Jazz Pharmaceuticals